Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04179 (
MnSOD
)
2,777
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Forkhead box transcription factor
FOXO3A
, an important regulator of cellular function, is thought to act as a tumor suppressor. We studied whether alterations in
FOXO3A
activity occur in prostate tumorigenesis. Our studies demonstrate that
FOXO3A
activity is negatively regulated by Akt/PKB through posttranslational modifications. In prostate cancer cells, Akt activation causes increased accumulation of
FOXO3A
and its binding chaperone protein 14-3-3 in the cytosol. Higher levels of
FOXO3A
in the cytosol correlated with phosphorylation at Ser253, which accounted for its nuclear exclusion. Dominant negative Akt approach in PC-3 cells increased
FOXO3A
accumulation in the nucleus, causing upregulation of the downstream target,
MnSOD
. Conversely, stable DU145-Akt over-expressing cells exhibited decreased
FOXO3A
levels in the nucleus. Similar findings were noted in prostate tumor specimens, in which marked cytoplasmic accumulation of
FOXO3A
and 14-3-3 in prostate tumors was observed with increasing Gleason grade, in contrast to exclusively nuclear accumulation in benign prostate cells. These findings correlate with decreased
FOXO3A
DNA binding activity along with down-modulation of
FOXO3A
transcriptional activity with increasing tumor grade. Our findings demonstrate that tumor associated alterations and redistribution of
FOXO3A
are frequent events in the etiology of prostate cancer.
...
PMID:Deregulation of FOXO3A during prostate cancer progression. 1942 79
E2F1 and
FOXO3
are two transcription factors that have been shown to participate in cellular senescence. Previous report reveals that E2F1 enhanced cellular senescence in human fibroblast cells, while FOXO transcription factors play against senescence by regulation reactive oxygen species scavenging proteins. However, their functional interplay has been unclear. Here we use E2F1 knock-out murine Embryonic fibroblasts (MEFs), knockdown RNAi constructs, and ectopic expression of E2F1 to show that it functions by negatively regulating
FOXO3
. E2F1 attenuates
FOXO3
-mediated expression of
MnSOD
and Catalase without affecting
FOXO3
protein stability, subcellular localization, or phosphorylation by Akt. We mapped the interaction between E2F1 and
FOXO3
to a region including the DNA binding domain of E2F1 and the C-terminal transcription-activation domain of
FOXO3
. We propose that E2F1 inhibits
FOXO3
-dependent transcription by directly binding
FOXO3
in the nucleus and preventing activation of its target genes. Moreover, knockdown of the Caenorhabditis elegans E2F1 ortholog efl-1 significantly extends lifespan in a manner that requires the activity of the C. elegans FOXO gene daf-16. We conclude that there is an evolutionarily conserved signaling connection between E2F1 and
FOXO3
, which regulates cellular senescence and aging by regulating the activity of
FOXO3
. We speculate that drugs and/or therapies that inhibit this physical interaction might be good candidates for reducing cellular senescence and increasing longevity.
...
PMID:E2F transcription factor 1 regulates cellular and organismal senescence by inhibiting Forkhead box O transcription factors. 2534 4